The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPM.L Regulatory News (MPM)

  • There is currently no data for MPM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Product Update

7 Dec 2016 11:00

RNS Number : 1944R
mporium Group PLC
07 December 2016
 

7 December 2016

mporium Group plc

("mporium" or the "Group")

Product Update

mporium Group plc (AIM:MPM), the "mobile native" technology firm, is pleased to provide a business update following the successful deployment of the Group's IMPACT product.

mporium is a technology company that enables brands, and the media agencies that serve them, to achieve better outcomes from digital advertising campaigns. The Group's unique technology delivers superior outcomes across all digital channels and on all devices, and the initial deployment of the technology is encouraging. Through the use of highly innovative proprietary technology, mporium delivers successful digital advertising campaigns particularly on mobile devices, from brand advertising to direct response.

Mobile as an advertising platform has proven challenging for both brands and media agencies. In a world where the majority of traffic comes from smartphones, brands and agencies urgently require a solution to this challenge. With the launch of the Group's IMPACT product, mporium believes that it is well positioned to address this challenge.

mporium IMPACT operates across search, social and display advertising venues, delivering sophisticated real-time content switching and bidding strategies that optimise outcomes for advertisers. This is achieved using a range of data inputs, including TV, news, sports and social media to manage in real-time the pricing, timing and selection of creative for digital advertising campaigns.

The business benefits are increased relevance for brands' audiences and superior consumer engagement. These benefits are achieved through the systematic and precise targeting of digital advertising campaigns, which are coordinated in real-time with the events that drive consumer engagement, to enhance efficiency and performance.

The Group's recent core investment in technology and data talent is already yielding benefits, including key relationships with a number of media agencies and brands. The extensive work undertaken with media agencies and brands has enabled the Group to determine its product market fit and the commercial model for mporium IMPACT.

The Group is at various stages of negotiations with such parties and expects to provide a further update in due course.

Enquiries:

mporium

020 3242 0515

Barry Moat

N+1 Singer (Nominated Adviser and Broker)

020 7496 3000

Gillian Martin

Alex Laughton-Scott

Buchanan

020 7466 5000

Charles Ryland

Vicky Watkins

About mporium PLC:

mporium is a London based technology company that works with agencies and brands to deliver better outcomes from digital advertising campaigns.

 

mporium's innovative and proprietary technology address the challenge of delivering increased relevance and superior consumer engagement in a smartphone dominated environment. The delivery of increased performance and strong agency relationships, will position mporium as a leading technology provider to both media agencies and brands.

 

For further information, please consult the mporium website: www.mporium.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUBVKRNRAURRA
Date   Source Headline
6th Jun 20147:00 amRNSAGM Statement
23rd May 20147:00 amRNSContract wins
22nd May 20145:00 pmRNSCompletion of audit
21st May 20145:06 pmRNSAnnual General Meeting
13th May 20147:00 amRNSResults for year ended 31 December 2013
29th Apr 201411:30 amRNSNotice of results & new product launch
31st Mar 20147:00 amRNSTOTAL VOTING RIGHTS
21st Mar 20147:00 amRNSAgreement with Affiliate Window
12th Mar 20143:39 pmRNSDirector/PDMR Shareholding
11th Mar 20144:35 pmRNSBlock Admission Application
7th Mar 20147:00 amRNSNew Customer and Sector Wins
20th Jan 20147:00 amRNSPRE-CLOSE TRADING UPDATE
17th Jan 201410:17 amRNSHoldings in Company
18th Dec 20137:00 amRNSFirst Day of Dealings
5th Mar 20107:00 amRNSOffer Update
5th Mar 20107:00 amRNSCompulsory Acquisition of Minster Shares
17th Feb 20107:14 amRNSBoard Changes, Issue of Deferred Consideration
17th Feb 20107:00 amRNSOffer Update
1st Feb 201012:50 pmRNSDirectorate Change
25th Jan 20105:51 pmRNSEPT Disclosure
20th Jan 201011:59 amRNSRule 8.3- Minster Pharmaceuticals PLC
14th Jan 20104:00 pmRNSPosting of Offer Document
14th Jan 20104:00 pmRNSPosting of Offer Document
13th Jan 20102:27 pmRNSRule 8.3- Minster Pharma PLC
4th Jan 20103:11 pmRNSAcquisition of Minster Pharmaceuticals
4th Jan 20103:11 pmRNSCash Offer
20th Nov 20097:00 amRNSInterim Results
21st Sep 20097:00 amRNSDirectorate Change
15th Sep 20093:31 pmRNSChange of Registered Office
14th Sep 20097:00 amRNSTonabersat at IHS Congress
23rd Jul 20097:00 amRNSSabcomeline Patent Filing
17th Jul 200910:39 amRNSDirector/PDMR Shareholding
6th Jul 20097:00 amRNSPublication of Aura Results
30th Jun 200911:30 amRNSResult of AGM
30th Jun 20097:01 amRNSAGM Statement
30th Jun 20097:00 amRNSRajinder Kumar Appointment
2nd Jun 20095:04 pmRNSAnnual Financial Report
29th May 200910:51 amRNSGrant of Share Option to Director
29th May 200910:47 amRNSDirector/PDMR Shareholding
28th May 20097:00 amRNSPreliminary Results
20th Apr 20097:00 amRNSKarl Keegan appointed CFO
17th Apr 20097:16 amRNSDirectorate Change
11th Feb 20093:39 pmRNSHolding(s) in Company
2nd Feb 20097:00 amRNSTempus Study Results
18th Dec 200811:52 amRNSHolding(s) in Company
4th Dec 20087:00 amRNSUS Licensing Consultant
14th Nov 20087:00 amRNSInterim Results
11th Nov 20087:00 amRNSNotice of Interim Results
22nd Oct 20087:00 amRNSPositive Phase II Results
30th Jun 20087:00 amRNSSymposium at AHS Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.